FdaApplication
BLA 125717
Identifiers
- fda_app_no: BLA125717
Properties
| Property | Value |
|---|---|
| applicant_name | Genetix Biotherapeutics Inc. |
| application_type | BLA |
| approval_date | 2022-08-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZYNTEGLO | — | 1.7-20 X 10^6CELL/ML | For Injection |
1 product